Zoetis (ZTS) Says FDA OKs APOQUEL to Control Itch and Allergy in Dogs
5/17/2013
More...
|
FDA Approves Janssen Biotech Inc.'s Simponi to Treat Ulcerative Colitis
5/16/2013
More...
|
Bayer AG (BAY.F), Algeta Win FDA Approval for Prostate Cancer Drug
5/16/2013
More...
|
FDA Wins New Genentech (RHHBY) OK for Lung Cancer Drug, Diagnostic Test
5/15/2013
More...
|
Arbor Pharmaceuticals Announces FDA Approval of First NDA
5/15/2013
More...
|
GlaxoSmithKline (GSK)'s BREO™ ELLIPTA™ Receives Regulatory Approval in U.S.
5/13/2013
More...
|
FDA Approves GlaxoSmithKline (GSK)/Theravance, Inc. (THRX) Drug for COPD Lung Disease
5/13/2013
More...
|
FDA OKs Novartis AG (NVS) Drug for a Form of Childhood Arthritis
5/13/2013
More...
|
Curis, Inc. (CRIS) Announces Approval of Erivedge® in Australia
5/10/2013
More...
|
Warner Chilcott, PLC (WCRX) Scores FDA Approval for Its New Oral Contraceptive
5/9/2013
More...
|
GW Pharmaceuticals Announces Sativex® Commercialization Approval in Italy
5/7/2013
More...
|
FzioMed Inc. Receives Approval for Dynavisc® in Australia
5/6/2013
More...
|
Bristol-Myers Squibb Company (BMY) Says FDA OKs Supplemental NDA for SUSTIVA
5/3/2013
More...
|
FDA Approves Merck & Co., Inc. (MRK)'s LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol
5/3/2013
More...
|
FDA Approves Shire plc (SHPG)'s Vyvanse for Children With ADHD
5/2/2013
More...
|
Raptor Pharmaceutical Inc. (RPTP) Receives FDA Approval for Procysbi
5/2/2013
More...
|
Teva Women's Health, Inc. (TEVA)'s Plan B Cleared for Over-the-Counter Sale to Younger Teens
5/1/2013
More...
|
FDA Approves Genentech (RHHBY)'s ACTEMRA® for Children Living With a Rare Form of Arthritis
5/1/2013
More...
|
FDA Approves CSL Behring's Kcentra
5/1/2013
More...
|
Protalix Biotherapeutics, Inc. (PLX) Release: UPLYSO™ (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
4/29/2013
More...
|
Optimer Pharmaceuticals, Inc. (OPTR)'s DIFICID® Tablets Approved in Australia
4/26/2013
More...
|
Becton, Dickinson and Company (BDX) Unit Receives FDA Approval for Second Simplist Drug
4/24/2013
More...
|
Roche (RHHBY) Release: Health Canada Approves PERJETA™, a New First-In-Class Targeted Therapy for the Treatment of HER2-Positive Metastatic Breast Cancer(1)
4/23/2013
More...
|
Warner Chilcott, PLC (WCRX) Announces FDA Approval of New Oral Contraceptive
4/23/2013
More...
|
Sucampo Pharmaceuticals, Inc. (SCMP) Wins Approval for Expanded Use of Amitiza in U.S.
4/23/2013
More...
|
European Commission (EC) Gives Green Light to New 6-in-1 Childhood Vaccine From Sanofi Pasteur (SASY.PA)
4/23/2013
More...
|
FDA Approves Novartis AG (NVS)'s Simbrinza for Glaucoma
4/22/2013
More...
|
Purdue Pharma L.P. Statement on FDA Approval of New Label for Reformulated Oxycontin® (Oxycodone HCL Controlled-Release) Tablets CII and Citizen Petition Regarding Withdrawal of Original Formulation Due to Safety
4/18/2013
More...
|
Sinovac Biotech Ltd. (SVA) Receives Commercial Approval in Mexico for Seasonal Flu Vaccine
4/18/2013
More...
|
CSL Behring Receives European Health Authorities' Approval of Berinert® for Short-Term Prophylaxis in Adults and Children
4/16/2013
More...
|
BioAlliance Pharma's Sitavig® Receives Market Authorization in the U.S. for the Treatment of Herpes Labialis
4/16/2013
More...
|
Sun Pharmaceutical Industries Ltd Gets FDA Nod for Generic Version of Januvia
4/16/2013
More...
|
Taro Pharmaceutical Industries Ltd. (TARO) Gets FDA Approval for Topicort Topical Spray
4/15/2013
More...
|
Warner Chilcott, PLC (WCRX) Receives FDA Approval of DORYX Delayed-Release 200 Mg Tablets
4/12/2013
More...
|
FDA Approves Duchesnay's Diclegis for Morning Sickness
4/9/2013
More...
|
Bausch & Lomb Receives FDA Approval for PROLENSA™
4/9/2013
More...
|
Biogen Idec Canada Release: Health Canada Approves TECFIDERA™ as a First-Line Oral Treatment for Multiple Sclerosis
4/9/2013
More...
|
FDA Approves Johnson & Johnson (JNJ)'s New Diabetes Drug
4/8/2013
More...
|
Genzyme Corporation (GENZ)'s AUBAGIO® Approved in Argentina for MS
4/8/2013
More...
|
FDA Approves Tris Pharma, Inc.'s Karbinal™ ER
4/3/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Approval for Oral Contraceptive
4/2/2013
More...
|
Health Canada Approves Next Pharmaceuticals' Relora®
4/2/2013
More...
|
Health Canada Approves UCB Canada Inc.'s NEUPRO® Patch for Treatment of Parkinson's Disease
4/2/2013
More...
|
Astellas Pharma Inc. (YPH.BE)'s Acofide Approved in Japan
3/29/2013
More...
|
Eisai Inc. (ESALF.PK) Announces FDA Approval for Aciphex Sprinkle
3/28/2013
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug
3/28/2013
More...
|
Bayer AG (BAY.F)'s Colorectal Cancer Drug Stivarga Bags Approval in Japan
3/26/2013
More...
|
Novartis AG (NVS)' TOBI Podhaler Gets FDA Approval
3/25/2013
More...
|
Genmab A/S (GEN.CO) and GlaxoSmithKline (GSK)'s Arzerra Receives Approval in Japan
3/25/2013
More...
|
Pfizer Inc. (PFE)'s XELJANZ Receives Approval in Japan
3/25/2013
More...
|
Bayer AG (BAY.F) Release: First New Colon Cancer Treatment Since 2006 Received Priority Review From Health Canada and is Now Approved for Canadian Patients With Metastatic Colorectal Cancer
3/25/2013
More...
|
FDA Approves Cangene Corporation (CC:CNJ)'s Treatment for Botulism
3/25/2013
More...
|
Veristat, Inc.'s Collaboration With Aegerion Pharmaceuticals, Inc. (AEGR) Contributes to FDA Approval of Juxtapid™
3/20/2013
More...
|
Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX) Type I Gaucher Disease Drug Uplyso Gets Brazilian Approval
3/19/2013
More...
|
Novartis AG (NVS) Says Alcon, Inc. (ACL)'s Eye Drug Jetrea Gets EU Approval
3/18/2013
More...
|
Navidea Biopharmaceuticals (NAVB)'s Lymphoseek Gets FDA Approval
3/15/2013
More...
|
Par Pharmaceutical Companies, Inc. (PRX) Begins Shipment of Generic Luvox CR®
3/15/2013
More...
|
ThromboGenics NV (TBGNF)'s JETREA® Granted EU Approval for Vitreomacular Traction (VMT), Including When Associated With Macular Hole of Diameter Less Than or Equal to 400 Microns
3/15/2013
More...
|
Astellas Pharma Canada, Inc. Receives a Notice of Compliance From Health Canada for Myrbetriq™ (Mirabegron)
3/8/2013
More...
|
Alexion's Soliris® (eculizumab) Receives Marketing Approval in Canada for Patients With Atypical HUS
3/6/2013
More...
|
EU Approves Roche (RHHBY)'s Perjeta to Treat Metastatic Breast Cancer
3/6/2013
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Announces Potential Additional Royalty Stream Related to EU Approval for Ilaris® (canakinumab) in Patients Suffering Acute Gouty Arthritis Attacks Who Cannot Gain Relief From Current Treatments
3/4/2013
More...
|
Hemispherx Biopharma (HEB) Gains Broad Treatment Expansion for Alferon N Injection® in Argentina
3/4/2013
More...
|
Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (LUN.CO) Wins Approval for Monthly Abilify Shot
3/1/2013
More...
|
Novartis AG (NVS)'s Ilaris Cleared for Gouty Arthritis in EU
3/1/2013
More...
|
Novozymes Biopharma's rAlbumin Approved in Japan as MAQUET Expands Into New Market
2/28/2013
More...
|
Lundbeck Inc. (LUN.CO) Given EU Nod for Alcohol Dependence Drug
2/28/2013
More...
|
CSL Behring Receives FDA Approval to Expand the Indication for Corifact®
2/28/2013
More...
|
FDA Approves Shionogi, Inc.'s Drug for Painful Intercourse in Women
2/27/2013
More...
|
Bayer HealthCare (BAY)'s Stivarga Gets FDA Approval for Treatment of Gastrointestinal Tract Tumor
2/26/2013
More...
|
Pfizer Inc. (PFE) Gains China Approval of Drug for Kinase-Specific Lung Cancer
2/26/2013
More...
|
FDA Approves Genentech (RHHBY)'s Drug for Late-Stage Metastatic Breast Cancer
2/26/2013
More...
|
Actavis' Generic Suboxone® Receives FDA Approval
2/25/2013
More...
|
Lupin Ltd. (LUPN.BO) Receives FDA Nod for Suprax Oral Suspension
2/22/2013
More...
|
FDA Approves Galderma Laboratories' Epiduo® to Treat Acne
2/20/2013
More...
|
FDA Approves Novartis AG (NVS)'s Zortress to Prevent Liver Transplant Rejection
2/19/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval of Generic Adderall XR®
2/15/2013
More...
|
Torrent Pharmaceuticals Ltd. Gains on FDA Nod for Generics of Actos
2/15/2013
More...
|
Aurobindo Pharma Gets FDA Nod for Anti-Diabetes Drug
2/15/2013
More...
|
Celgene Corporation (CELG) Gains SFDA Approval for Multiple Myeloma Treatment
2/13/2013
More...
|
FDA Approves Celgene Corporation (CELG)'s Pomalyst for Advanced Multiple Myeloma
2/12/2013
More...
|
Takeda Pharmaceuticals' Alogliptin Wins FDA Approval
2/8/2013
More...
|
Sun Pharmaceutical Industries Ltd Receives U.S. Nod for Cancer Drug "Doxil"
2/7/2013
More...
|
FDA Approves Perrigo Company (PRGO)'s NDA for Testosterone Gel 1%
2/6/2013
More...
|
FDA OKs Warner Chilcott, PLC (WCRX)'s Ulcerative Colitis Product
2/6/2013
More...
|
Sanofi (France) (SAN.PA) Says Zaltrap Approved in Europe for Bowel Cancer
2/5/2013
More...
|
Health Canada Approves Seattle Genetics, Inc. (SGEN)'s ADCETRIS® for Two Lymphoma Indications
2/4/2013
More...
|
FDA Approves Hyperion Therapeutics Drug for Urea Cycle Disorders
2/4/2013
More...
|
Sanofi (France) (SAN.PA)'s Diabetes Drug Lyxumia Approved in Europe
2/4/2013
More...
|
Biotest Pharmaceuticals Release: BIVIGAM™ [Immune Globulin Intravenous (Human), 10% Liquid] is the First New IVIG Product Approved With a Validated and FDA Approved Thrombin Generation Assay (TGA) Test
2/1/2013
More...
|
FDA OKs Isis Pharmaceuticals, Inc. (ISIS), Genzyme Corporation (GENZ)'s Drug for Rare Cholesterol Disorder
2/1/2013
More...
|
FDA Approves 3 New Diabetes Drugs From Takeda Pharmaceutical Co. Ltd. (TKPYY)
1/29/2013
More...
|
FDA OKs Merck & Co., Inc. (MRK) OTC Version of Overactive Bladder Drug
1/28/2013
More...
|
Pfizer Inc. (PFE) Gets FDA Approval for Vaccine for Older Children
1/28/2013
More...
|
FDA Gives Nod to Novartis AG (NVS)'s Gleevec for Pediatric ALL
1/28/2013
More...
|
Genentech (RHHBY)'s Avastin Approved for Wider Use in Colorectal Cancer
1/24/2013
More...
|
Meda AB (MEDA-A.ST)'s Dymista Approved in Europe
1/24/2013
More...
|
FDA Approves Novartis AG (NVS)'s Exjade in Patients With Genetic Blood Disorder
1/24/2013
More...
|
Lupin Ltd. (LUPN.BO) Gets U.S. Nod for 7th Oral Contraceptive
1/23/2013
More...
|
Allergan Inc. (AGN)'s Botox Gets FDA Approval for Overactive Bladder
1/23/2013
More...
|
Novartis AG (NVS) Wins EU Backing for First Meningitis B Vaccine
1/22/2013
More...
|
Novo Nordisk A/S (NVO) Gets Green Light for Tresiba in EU
1/22/2013
More...
|
FDA Approves Octaplas® Expanding Octapharma USA, Inc.'s Transfusion Medicine Therapies
1/22/2013
More...
|
ThromboGenics NV (TBGNF), Novartis AG (NVS) Win EU OK for Jetrea Eye Drug
1/21/2013
More...
|
NuPathe Inc. (PATH) Shares Jump After FDA Approves Migraine Patch
1/21/2013
More...
|
FDA Approves Protein Sciences Corporation's Egg-Free Flu Vaccine Flubok
1/20/2013
More...
|
Forest Laboratories, Inc. (FRX) Says Bystolic Approved in Canada
1/18/2013
More...
|
pSivida Corp (PSDV) Announces Spain Grants ILUVIEN® Marketing Approval for Chronic Diabetic Macular Edema
1/17/2013
More...
|
Stryker Corporation (SYK)'s Alzheimer's Dx Test Gets EU Approval
1/17/2013
More...
|
Santarus Inc. (SNTS) Wins FDA Approval for Ulcerative Colitis Therapy; Will Add 85 New Sales Reps to Support Drug
1/17/2013
More...
|
Health Canada Approves Novartis Oncology (NVS)'s AFINITOR for Breast Cancer
1/16/2013
More...
|
EU Approves Johnson & Johnson (JNJ)'s Single Pill Prezista for HIV
1/16/2013
More...
|
BioForward (WI) Collaborates With University of Wisconsin Students in PR Campaign
1/11/2013
More...
|
Janssen-Cilag AG Release: ZYTIGA® Approved in the EU for Use in the Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy
1/11/2013
More...
|
FDA Approves Bayer HealthCare (BAY)'s First New IUD in 12 Years, Skyla
1/10/2013
More...
|
FDA Approves Celgene Corporation (CELG)'s VARIZIG®
1/9/2013
More...
|
INNOPHARMA Announces FDA Approval of Acetylcysteine Injection
1/8/2013
More...
|
Afaxys Pharmaceuticals Enters Public Health Sector With Its First Generic Oral Contraceptive
1/7/2013
More...
|
FDA Approves Johnson & Johnson (JNJ) TB Drug; First in 40 Years
1/7/2013
More...
|
Watson Pharmaceuticals, Inc. (WPI)'s Generic Lysteda® Receives FDA Approval
1/3/2013
More...
|
EMD Group (EMD Serono, Inc. (Rockland)) and Pfizer Inc. (PFE) Announce FDA Approval of Rebif® Rebidose®
1/3/2013
More...
|
FDA Approves Salix Pharmaceuticals, Ltd. (SLXP)'s Diarrhea Drug for HIV/AIDS Patients
1/3/2013
More...
|
Bristol-Myers Squibb Company (BMY)-Pfizer Inc. (PFE)'s Blood Thinner Eliquis Wins FDA Approval
1/3/2013
More...
|
Breckenridge Pharmaceutical, Inc. Announces Approval of Rizatriptan Benzoate Tablets
1/2/2013
More...
|
FDA Approves Aegerion Pharmaceuticals, Inc. (AEGR)'s Juxtapid
1/1/2013
More...
|
Alexza Pharmaceuticals, Inc. (ALXA)'s Agitation Drug Gets FDA Approval
1/1/2013
More...
|
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis Approved in Japan
12/27/2012
More...
|
UCB, Inc. (UCBJF.PK) Gets Japan Clearance for Two New Drugs
12/27/2012
More...
|
Novo Nordisk A/S (NVO) Gains as Japan Approves Ryzodeg
12/27/2012
More...
|
FDA Approves Roche (RHHBY)'s Tamiflu for Infants
12/27/2012
More...
|
FDA Approves NPS Pharmaceuticals, Inc. (NPSP)'s Gattex to Treat Short Bowel Syndrome
12/26/2012
More...
|
Biotest AG Receives FDA Approval for BIVIGAM to Treat Primary Humoral Immunodeficiency
12/26/2012
More...
|
BioAlliance Pharma Announces the Registration of Sitavig® in European Countries
12/21/2012
More...
|
Breckenridge Pharmaceutical, Inc. Announces Approval for Lansoprazole Delayed-Release Rx Capsules
12/19/2012
More...
|
Health Canada Approves Paladin Labs Inc. (CC:PLB) Silenor New Drug Submission
12/18/2012
More...
|
FDA Approves GlaxoSmithKline (GSK) Drug for Treatment of Anthrax
12/18/2012
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) Wins FDA Approval for Drug to Treat Rare Leukemias
12/18/2012
More...
|
Novartis AG (NVS) Drug Signifor® Gains FDA Approval for Cushing's Disease
12/17/2012
More...
|
FDA Approves GlaxoSmithKline (GSK)'s Four-Strain Seasonal Influenza Vaccine for Use in the U.S.
12/17/2012
More...
|
Roche (RHHBY) Wins EU Backing for Perjeta Breast Cancer Drug
12/14/2012
More...
|
Veridex, LLC Release: CellSearch® "Liquid Biopsy" Approved for Breast Cancer Patients in China
12/13/2012
More...
|
Sucampo Pharmaceuticals, Inc. (SCMP) Gets Nod for Glaucoma Drug From FDA
12/12/2012
More...
|
Johnson & Johnson (JNJ)'s Zytiga Wins Approval for Early Prostate Cancer Use
12/11/2012
More...
|
European Commission (EC) Clears Wider Use for Genzyme Corporation (GENZ) Cancer Treatment
12/7/2012
More...
|
Emerging World Pharma Inc. Strategic Partner African Global Pharma (AGP) GH Receives Ghana Food and Drug Board Packaging and Insert Approvals for Paracetamol Tablets
12/6/2012
More...
|
Trimedica Limited: European Commission (EC) Approves New Xaluprine Formulation
12/5/2012
More...
|
Cystic Fibrosis Drug From Vertex Pharmaceuticals (MA) (VRTX) is Approved by Canadian Regulators
12/3/2012
More...
|
Sanofi Pasteur (SASY.PA)'s Meningococcus Vaccine Menactra Approved for Infants Down to 9 Months
12/3/2012
More...
|
Exelixis, Inc. (EXEL)'s FDA Approves Cometriq to Treat Rare Type of Thyroid Cancer
12/3/2012
More...
|
AstraZeneca PLC (AZN) Heart Drug Wins Approval in China
11/30/2012
More...
|
Mylan Pharmaceuticals, Inc. (MYL) Gets FDA Approval for New Product
11/29/2012
More...
|
Perrigo Company (PRGO) Announces FDA Final Approval of Betamethasone Valerate Foam 0.12%
11/28/2012
More...
|
Par Pharmaceutical Companies, Inc. (PRX) Begins Shipment of Generic Symbyax®
11/28/2012
More...
|
Emerging World Pharma Inc. Strategic Partner African Global Pharma (AGP) Approval From Food & Drugs Board Ghana for Anti-Malarial Pharmaceutical Gloderp® in Final Stages
11/28/2012
More...
|
Almirall, Ironwood Pharmaceuticals Drug for IBS Gets Regulatory Approval in Europe
11/28/2012
More...
|
Bayer AG (BAY.F)'s Eylea Gets Green Light in Europe for Wet AMD
11/27/2012
More...
|
FDA Approves Novel Novartis AG (NVS) Seasonal Flu Vaccine
11/26/2012
More...
|
Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ)'s Once-Daily, Oral Aubagio Approved in Australia to Treat MS
11/26/2012
More...
|
All Wales Strategic Medical Group Approves Zebinix Anti-Epileptic Treatment
11/26/2012
More...
|
Bristol-Myers Squibb Company (BMY)-Pfizer Inc. (PFE) Anticlot Drug Gets Key EU Approval
11/23/2012
More...
|
GlaxoSmithKline (GSK) Receives FDA OK for PROMACTA
11/23/2012
More...
|
EU OKs Bristol-Myers Squibb Company (BMY)-AstraZeneca PLC (AZN) Diabetes Drug After U.S. Rejection
11/16/2012
More...
|
Syngenta Corporation Secures EU Approval For Next Generation Fungicide
11/13/2012
More...
|
Janssen Therapeutics's Prezista 800 Mg Tablet Receives FDA Approval
11/12/2012
More...
|
Watson Pharmaceuticals, Inc. (WPI)'s Generic Revatio® Receives FDA Approval
11/12/2012
More...
|
FDA Approves Pfizer Inc. (PFE)'s Rheumatoid Arthritis Pill
11/9/2012
More...
|
Health Canada Approves Eli Lilly Canada Inc. (LLY)'s Cymbalta for Knee Pain
11/8/2012
More...
|
Cardium Therapeutics, Inc. (CXM) Release: European Union's First Gene Therapy Approval Represents Major Advancement For Industry
11/6/2012
More...
|
Johnson & Johnson (JNJ)-Bayer AG (BAY.F) Blood Thinner Wins Backing for Lung, Leg Clots
11/5/2012
More...
|
Sihuan Pharmaceutical Holdings Group Ltd. Announces SFDA Approval for Ulcer Drug
11/2/2012
More...
|
European Commission (EC) OKs uniQure's First High-Price Gene Therapy for Rare Disease
11/2/2012
More...
|
European Commission (EC) Approves Eli Lilly and Company (LLY)'s Cialis® (Tadalafil) Tablets for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia
10/30/2012
More...
|
FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Leukemia Drug
10/30/2012
More...
|
Watson Pharmaceuticals, Inc. (WPI) Receives FDA Approval for Generic Actos®
10/29/2012
More...
|
Par Pharmaceutical Companies, Inc. (PRX) Receives Final Approval to Market Tretinoin Capsules
10/26/2012
More...
|
Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY) Release: EU Approval Granted for Trajenta® (linagliptin) Tablets as Add-on Therapy to Insulin in Adults With Type 2 Diabetes
10/26/2012
More...
|
LEO Pharma Receives FDA Approval for Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064% for Body Plaque Psoriasis
10/26/2012
More...
|
Par Pharmaceutical Companies, Inc. (PRX) Receives Final Approval to Market Tretinoin Capsules
10/25/2012
More...
|
Novartis AG (NVS) Drug Certican® Approved by European Health Authorities to Prevent Organ Rejection in Adult Liver Transplant Patients
10/25/2012
More...
|
FDA Approves Eisai Inc. (ESALF.PK) Drug for Epileptic Seizures
10/24/2012
More...
|
Another Supernus Pharmaceuticals (SUPN) Epilepsy Drug Gets FDA Nod
10/23/2012
More...
|
Nuvo Research Inc. (NRI.TO) and Galderma Pharma S.A. Announce FDA Approval of Pliaglis
10/22/2012
More...
|
Scil Proteins GmbH Obtains European Medicines Agency Approval for Commercial Production of Reteplase
10/22/2012
More...
|
ViroPharma Incorporated (VPHM) Release: Health Canada Approves New Drug Submission for Cinryze™ (C1 Inhibitor [Human])
10/22/2012
More...
|
FDA: ThromboGenics NV (TBGNF) Main Drug Cleared for U.S. Launch
10/18/2012
More...
|
Watson Pharmaceuticals, Inc. (WPI)'s Generic Avapro® Receives FDA Approval
10/15/2012
More...
|
Watson Pharmaceuticals, Inc. (WPI)'s Generic Sanctura XR® Receives FDA Approval
10/15/2012
More...
|
Inovio Pharmaceuticals (INO) Animal Health Subsidiary's GHRH Treatment Approved in New Zealand
10/15/2012
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces Approval of Phentermine Capsules and Delayed Launch
10/15/2012
More...
|
FDA Approves Mission Pharmacal Company's Plan to Sell Osteoporosis Drug
10/12/2012
More...
|
FDA Approves Expanded Indication for Genentech (RHHBY)'s ACTEMRA® in Rheumatoid Arthritis
10/12/2012
More...
|
FDA Approves Celgene Corporation (CELG)'s Abraxane for Lung Cancer
10/12/2012
More...
|
Actavis Receives Approval of Generic Tiazac® (Diltiazem Hydrochloride Extended-Release Capsules) in the U.S.
10/10/2012
More...
|
Perrigo Company (PRGO) Receives FDA Approval to Market Mini Nicotine Lozenges
10/10/2012
More...
|
Bayer AG (BAY.F)'s Contraceptive Flexyess Gets EU Approval
10/10/2012
More...
|
Senomyx, Inc. (SNMX) Announces Approval of Its Savory Flavors and S2383 Flavor Ingredient in the European Union
10/9/2012
More...
|
Sigma-Tau Pharmaceuticals Receives FDA Approval of CYSTARAN™
10/4/2012
More...
|
InterMune, Inc. (ITMN) Release: Health Canada Approves Esbriet® as First Treatment for Fatal Lung Disease
10/3/2012
More...
|
FDA Approves Abbott Laboratories (ABT)'s Humira as Ulcerative Colitis Therapy
10/3/2012
More...
|
NextWave Pharmaceuticals Receives FDA Approval of Quillivant XR™ for Once-Daily Treatment of ADHD
10/1/2012
More...
|